Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term observational follow-up of bicyclol tablets for acute drug-induced liver injury
CTR20231453Phase 4Active
- Sponsor
- Beijing Union Pharmaceutical Factory
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bicyclol in Drug-induced hepatitis (DILI), sponsored by Beijing Union Pharmaceutical Factory. Started Aug 2023; status: active.
02
Drugs
bicyclol
03
Conditions
Drug-induced hepatitis (DILI)
Beyond the preview
Go deeper on CTR20231453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231453.